These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1295821

  • 1. The effects of growth hormone therapy on spontaneous sexual development.
    Stanhope R, Albanese A, Hindmarsh P, Brook CG.
    Horm Res; 1992; 38 Suppl 1():9-13. PubMed ID: 1295821
    [Abstract] [Full Text] [Related]

  • 2. Management of growth hormone deficiency through puberty.
    Stanhope R, Uruena M, Hindmarsh P, Leiper AD, Brook CG.
    Acta Paediatr Scand Suppl; 1991; 372():47-52; discussion 53. PubMed ID: 1927519
    [Abstract] [Full Text] [Related]

  • 3. Final height and pubertal development in children with growth hormone deficiency after long-term treatment.
    Frisch H, Birnbacher R.
    Horm Res; 1995; 43(4):132-4. PubMed ID: 7750913
    [Abstract] [Full Text] [Related]

  • 4. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM.
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [Abstract] [Full Text] [Related]

  • 5. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 6. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
    Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A.
    Horm Res; 1997 Oct; 48(2):62-71. PubMed ID: 9251922
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E, Kriström B, Jonsson B, Albertsson-Wikland K, study group.
    BMC Endocr Disord; 2015 Dec 18; 15():84. PubMed ID: 26682747
    [Abstract] [Full Text] [Related]

  • 8. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.
    Crowe BJ, Rekers-Mombarg LT, Robling K, Wolka AM, Cutler GB, Wit JM, European Idiopathic Short Stature Group.
    J Clin Endocrinol Metab; 2006 Jan 18; 91(1):169-75. PubMed ID: 16263828
    [Abstract] [Full Text] [Related]

  • 9. The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty.
    Stanhope R, Brook CG.
    Eur J Pediatr; 1988 Dec 18; 148(3):200-2. PubMed ID: 3145878
    [Abstract] [Full Text] [Related]

  • 10. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T, Yoshizawa A, Tanae A, Hibi I, Shizume K.
    Horm Res; 1990 Dec 18; 33 Suppl 4():102-5. PubMed ID: 2147164
    [Abstract] [Full Text] [Related]

  • 11. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K.
    J Clin Endocrinol Metab; 1989 Aug 18; 69(2):221-6. PubMed ID: 2526818
    [Abstract] [Full Text] [Related]

  • 12. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B.
    Horm Res; 2003 Aug 18; 60(Suppl 1):68-73. PubMed ID: 12955021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist.
    Job JC, Toublanc JE, Landier F.
    Horm Res; 1994 Aug 18; 41(5-6):177-84. PubMed ID: 7959618
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases.
    Hokken-Koelega AC, Saenger P, Cappa M, Greggio N, International Workshop on Management of Puberty for Optimum Auxological Results.
    J Pediatr Endocrinol Metab; 2001 Jul 18; 14 Suppl 2():945-52. PubMed ID: 11529400
    [Abstract] [Full Text] [Related]

  • 17. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM, Whitehouse RH, Hughes PC, Carter BS.
    J Pediatr; 1976 Dec 18; 89(6):1000-8. PubMed ID: 993900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term treatment in children with hypopituitarism: pubertal development and final height.
    Birnbacher R, Riedl S, Frisch H.
    Horm Res; 1998 Dec 18; 49(2):80-5. PubMed ID: 9485176
    [Abstract] [Full Text] [Related]

  • 20. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 18; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.